Laser, IPL, or Cryotherapy for Age Spots: What the Mechanisms Actually Predict

Age spots, known clinically as solar lentigines, are flat brown patches caused by decades of ultraviolet exposure. At the cellular level, they represent a localized increase in melanin production and, in many cases, an increased number of melanocytes along the basal layer of the epidermis. Because the pigment sits in a defined location, they respond well to procedures that selectively destroy or disperse melanin. Three office-based options dominate the conversation: pigment-targeting lasers, intense pulsed light, and cryotherapy. They are often discussed as if they were interchangeable. Mechanistically, they are not.

How pigment lasers work. Q-switched and picosecond lasers rely on a principle called selective photothermolysis. The device emits light at a wavelength that melanin absorbs strongly, typically 532, 694, 755, or 1064 nanometers, delivered in pulses shorter than the time it takes heat to spread out of the pigment target. The melanin heats and fragments before surrounding tissue is significantly injured. The fragmented pigment is then cleared by the immune system over days to weeks, and the treated spot often darkens, crusts, and flakes off within 7 to 14 days. Because the energy is confined to the pigment, well-performed laser treatment tends to spare the surrounding skin, which is why many clinicians consider it the most precise of the three options for discrete lentigines.

How intense pulsed light works. IPL is not a laser. It emits a broad spectrum of light, roughly 500 to 1200 nanometers, filtered to favor wavelengths absorbed by melanin and hemoglobin. That breadth is both its strength and its limitation. IPL can treat a full field of mottled sun damage in one pass, addressing dozens of faint spots and background redness simultaneously, which lasers treating spot by spot do less efficiently. The tradeoff is lower selectivity. Because IPL also heats blood vessels and water in the skin, energy settings must be conservative, and faint or deeper pigment may need 3 to 5 sessions rather than the 1 to 2 often sufficient with a Q-switched laser on a well-defined spot.

How cryotherapy works. Liquid nitrogen destroys tissue by freezing it, typically applied for a few seconds per spot. Melanocytes are notably more sensitive to cold injury than surrounding keratinocytes, which is the biological rationale for using cryotherapy on pigmented lesions. It is fast, inexpensive, and widely available. But the destruction is not pigment-selective in the way laser light is. Freeze too briefly and pigment persists. Freeze too long and the melanocytes in the treated zone are wiped out entirely, leaving a permanently white patch, a complication called hypopigmentation that is more visible on tanned or darker skin than the original spot was.

What the comparison looks like in practice. Head-to-head studies have generally found that Q-switched lasers clear individual lentigines with fewer treatments and lower rates of hypopigmentation than cryotherapy, particularly on the hands and face. IPL performs well for diffuse photodamage but is less predictable on thick or dark solitary spots. Cryotherapy remains a reasonable choice for a small number of lesions in patients with lighter skin, especially where laser access is limited, but precision depends heavily on operator technique.

Skin tone changes the calculation. In deeper skin tones, Fitzpatrick types IV to VI, background melanin in the epidermis competes for laser and IPL energy, raising the risk of burns, post-inflammatory hyperpigmentation, and hypopigmentation. Longer wavelengths such as 1064 nanometers, lower fluences, and picosecond pulses reduce but do not eliminate this risk. Cryotherapy carries a particularly high risk of permanent light patches in darker skin and is generally discouraged for cosmetic lentigo removal in those patients.

One caution that outranks all three treatments. A lesion assumed to be an age spot can occasionally be lentigo maligna, an early form of melanoma that mimics a benign lentigo. Destroying it with light or cold removes the visible evidence without treating the disease and delays diagnosis. Any spot that is new after age 60, growing, irregularly bordered, or unevenly colored deserves dermatologic evaluation, and often dermoscopy or biopsy, before any cosmetic treatment.

Recurrence is expected, not a failure. None of these procedures changes the underlying tendency of sun-damaged skin to produce new lentigines. The melanocytes that remain still respond to ultraviolet light. Studies following patients after successful clearance consistently show gradual repigmentation or new spots over 1 to 2 years without strict photoprotection. Daily broad-spectrum sunscreen, ideally a tinted formula containing iron oxides that block visible light, is the intervention that determines how long results last.

The practical summary: lasers offer the most selective destruction for defined spots, IPL suits diffuse mottling across larger areas, and cryotherapy is a low-tech option best reserved for lighter skin and experienced hands. Diagnosis first, mechanism-matched treatment second, sun protection always.

Related reading: Laser, IPL, or Cryotherapy for Age Spots: What the Mechanisms Actually Predict.